| Structure |
Chemical Name |
CAS |
MF |
 |
Blonanserin impurity H |
|
|
|
|
Captopril impurity 1 |
|
|
|
|
Cefodizime Impurity 6 |
|
|
|
|
Clindamycin Impurity 5 |
|
|
|
|
Dapoxetine Impurity 16 |
|
|
|
|
Doxofylline Impurity 5 |
|
|
|
|
Everolimus impurity B |
|
|
|
|
FeBuxostat Impurity 27 |
|
|
 |
Fosaprepitant Impurity 1 |
172822-01-4 |
C23H22F7N4O6P |
 |
Hydroxychloroquine Impurity 7 |
47493-14-1 |
C20H28ClN3O2 |
 |
Indacaterol Impurity 12 |
1026461-20-0 |
C22H24N2O3 |
|
|
Isavuconazole Impurity 15 |
|
|
|
|
Isavuconazole Impurity 3 |
|
|
|
|
Isavuconazole Impurity 8 |
|
|
|
|
Lenvatinib Impurity 3 |
|
|
|
|
Linagliptin Impurity 44 |
|
|
|
|
MiraBegron impurity E |
|
|
|
|
Moxifloxacin Impurity 16 |
|
|
 |
Nifedipine Impurity H |
74936-71-3 |
C16H16N2O6 |
|
|
Plerixafor Impurity 3 |
|
|
|
|
Posaconazole Impurity 27 |
|
|
 |
Posaconazole Impurity 44 |
357189-97-0 |
C21H20F2N4O3 |
|
|
Pramipexole Impurity 10 |
|
|
|
|
rac N-Propyl-2-cyanimidopyrrolidine-5-acetic Acid |
|
|
|
|
sofosBuvir Impurity 33 |
|
|
|
|
sofosBuvir impurity 49 |
|
|
|
|
SofosBuvir Impurity 55 |
|
|
 |
Tenofovir Impurity W |
1244022-55-6 |
C15H24N5O8P |
|
|
TerButaline Ep Impurity B |
|
|
 |
Timolol EP Impurity H |
158636-97-6 |
C13H24N4O3S |
|
|
Tirofiban Impurity 11 |
|
|
 |
Tofacitinib Impurity 45 |
2407039-29-4 |
C16H20N6O2 |
|
|
Tofacitinib impurity S |
|
|
|
|
Trelagliptin Impurity 25 |
|
|
 |
L-アラニン2-(2-アミノ-6-オキソ-1,6-ジヒドロ-9H-プリン-9-イルメトキシ)エチル |
84499-64-9 |
C11H16N6O4 |
 |
Lidocaine EP Impurity F |
142713-08-4 |
C14H22N2O |
|
|
Ampicillin Impurity P |
|
|
|
|
Cefdinir Impurity B (CP) |
|
|
|
|
Cloxacillin Impurity A |
|
|
 |
EM-201 |
857839-61-3 |
C37H65NO12 |
![(4R,5S,6S)-6-[(R)-1-ヒドロキシエチル]-4-メチル-7-オキソ-3-[[(3S,5S)-5-[(ジメチルアミノ)カルボニル]-1-[[(1S,2R)-1-[[2,3-ジヒドロ-5-カルボキシ-3β-メチル-4-[[5β-[(ジメチルアミノ)カルボニル]ピロリジン-3β-イル]チオ]-1H-ピロール]-2β-イル]-2-ヒドロキシプロピル]カルボニル]ピロリジン-3-イル]チオ]-1-アザビシクロ[3.2.0]ヘプタ-2-エン-2-カルボン酸](/CAS/20210111/GIF/166901-45-7.gif) |
(4R,5S,6S)-6-[(R)-1-ヒドロキシエチル]-4-メチル-7-オキソ-3-[[(3S,5S)-5-[(ジメチルアミノ)カルボニル]-1-[[(1S,2R)-1-[[2,3-ジヒドロ-5-カルボキシ-3β-メチル-4-[[5β-[(ジメチルアミノ)カルボニル]ピロリジン-3β-イル]チオ]-1H-ピロール]-2β-イル]-2-ヒドロキシプロピル]カルボニル]ピロリジン-3-イル]チオ]-1-アザビシクロ[3.2.0]ヘプタ-2-エン-2-カルボン酸 |
166901-45-7 |
C34H50N6O10S2 |
 |
Oxacillin Sodium Impurity D(EP) |
1642559-63-4 |
C18H21N3O4S |
|
|
Oxacillin Sodium Impurity J(EP) |
|
|
|
|
Spectinomycin Impurity A |
|
|
 |
Gabapentin EP Impurity G |
1500558-49-5 |
C10H19NO2 |
 |
2-butyrylbenzoic acid |
19666-03-6 |
C11H12O3 |
|
|
Cefminox sodium impurities D |
|
|
 |
(R)-5-chloro-N-(4-(3-oxomorpholino)phenyl)-N- ((2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide |
1879903-65-7 |
C19H18ClN3O5S |
 |
Cefmetazole impurity |
56796-19-1 |
C28H27N7O5S3 |
 |
3-ethylisobenzofuran-1(3H)-one |
17475-41-1 |
C10H10O2 |
 |
Ivabradine Impurity 21 HCl |
304465-03-0 |
C26H34N2O5 |
|
|
Moxifloxacin EP Impurity C HCl |
|
|
 |
Moxifloxacin Impurity 23 |
855661-74-4 |
C21H24FN3O4 |
 |
Solifenacin Related Compound 18 |
1225338-27-1 |
C23H26N2O2 |
 |
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
 |
Tofacitinib Related Compound |
1206824-85-2 |
C10H18ClN3O |
 |
Fluvastatin EP impurity A -G |
93957-58-5 |
C24H26FNO4 |
 |
PWKRNMKZGWGSDV-UHFFFAOYSA-N |
1422960-88-0 |
C33H34ClN4+ |
![sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate](/CAS/20180527/GIF/1329502-92-2.gif) |
sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate |
1329502-92-2 |
C33H41N4NaO7 |
 |
QFJAHHNMKTWTGZ-DZAPPIOQSA-N |
2045402-27-3 |
C35H36ClNO4S |
![N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide](/CAS/20200119/GIF/1374226-74-0.gif) |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
1374226-74-0 |
C18H24N2O |
 |
BJQMFFOQQWEWAF-DGBYXFBUSA-N |
1709825-83-1 |
C31H41ClO8 |
![(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20180629/GIF/CB03954746.gif) |
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C23H29FN6O4S |
 |
(5-Ethyl-1H-imidazol-4-yl)methanol |
38603-74-6 |
C6H10N2O |
 |
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
1810761-43-3 |
C15H16N2O3S |
 |
ethylidene phthalide |
61658-90-0 |
C10H8O2 |
![6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one](/CAS/20180629/GIF/1361569-18-7.gif) |
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one |
1361569-18-7 |
C19H15FN8O |
 |
3-トリフルオロメチル-5-(P-トリル)-1H-ピラゾール |
219986-64-8 |
C11H9F3N2 |
 |
5-メチル-3-フェニルイソオキサゾール-4-カルボン酸 |
1136-45-4 |
C11H9NO3 |
|
|
Bendamustine Impurity 26 |
|
|
|
|
Canagliflozin Impurity 26 |
|
|
 |
Edoxaban Impurity 37 |
2081883-50-1 |
C14H27N3O3 |
|
|
Imatinib Impurity 10 |
|
|
 |
Levofloxacin Impurity 19 |
|
C18H20FN3O4 |
 |
Olanzapine Impurity K |
|
C17H20N4S |
|
|
Ticagrelor Related Compound 55 |
|
|
|
|
Ticagrelor Related Compound 73 |
|
|
|
|
Vildagliptin Impurity 10 |
|
|
 |
Cefaclor Impurity 2 |
722547-49-1 |
C17H18N2O3 |
|
|
Cefodizime Impurity F |
|
|
|
|
Olaparib Impurity F |
|
|
|
|
Ornidazole Impurity G |
|
|
|
|
Pidotimod Impurity L |
|
|
|
|
Tadalafil Impuirty 20 |
2924098-58-6 |
|
|
|
Tenofovir Impurity 53 |
|
|
 |
(S)-3-(4-benzylphenoxy)tetrahydrofuran |
|
C17H18O2 |
 |
Ampicillin |
1207726-28-0 |
C24H26N4O5S |
 |
ethyl 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-
carboxylate |
2375033-35-3 |
C18H20N2O3S |
 |
(S)-Indacaterol |
1384188-70-8 |
C24H29ClN2O3 |
 |
Cefminox Sodium Impurity 3 |
1420072-83-8 |
C16H21N7O6S4 |
|
|
Edaravone Impurity 26 |
152494-76-3 |
|
|
|
Teneligliptin Impurity 15 |
|
|
|
|
Nicergoline EP Impurity I |
|
|
![Carbamic acid, N-[(4-methylphenyl)sulfonyl]-](/CAS/20200331/GIF/107628-27-3.gif) |
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
 |
9H-Purin-6-amine, 9-(2-chloropropyl)- |
50615-40-2 |
C8H10ClN5 |
|
|
Hyoscine Butylbromide EP Impurity G |
|
|
 |
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
![[1,1-Biphenyl]-2,2,4,4,5,5-hexol(9CI)](/CAS/GIF/76625-61-1.gif) |
[1,1-Biphenyl]-2,2,4,4,5,5-hexol(9CI) |
76625-61-1 |
C12H10O6 |
 |
lamivudine sulfoxide |
160552-55-6 |
C8H11N3O4S |
 |
Vitamin B12 e-Monocarboxylic Acid |
26264-28-8 |
C63H87CoN13O15P |